Difference between revisions of "Degenerative Joint Disease"
m |
|||
(5 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | + | [[Image:DJD horse.jpg|right|thumb|100px|<small><center>DJD in a horse (Image sourced from Bristol Biomed Image Archive with permission)</center></small>]] | |
− | Also known as: '''''DJD — Osteoarthritis — Degenerative | + | |
+ | Also known as: '''''DJD — Osteoarthritis — Degenerative arthritis — Osteroarthrosis''''' | ||
==Introduction== | ==Introduction== | ||
− | |||
Degenerative joint disease is the '''progressive deterioration of articular cartilage''' and is characterised by hyaline cartilage thinning, joint effusion and periarticular osteophyte formation. | Degenerative joint disease is the '''progressive deterioration of articular cartilage''' and is characterised by hyaline cartilage thinning, joint effusion and periarticular osteophyte formation. | ||
− | |||
− | |||
'''Chondrocyte necrosis''' is initiated, degradative enzymes are released and '''synovitis''', continued cartilage degradation and '''inflammation''' occur. There is loss of proteoglycans and lubrication in the joint. | '''Chondrocyte necrosis''' is initiated, degradative enzymes are released and '''synovitis''', continued cartilage degradation and '''inflammation''' occur. There is loss of proteoglycans and lubrication in the joint. | ||
Line 16: | Line 14: | ||
DJD is the '''end-stage''' to many common diseases of '''small and large animals''' and therefore prompt diagnosis and management of these diseases is critical in preventing the condition. | DJD is the '''end-stage''' to many common diseases of '''small and large animals''' and therefore prompt diagnosis and management of these diseases is critical in preventing the condition. | ||
− | ==Predisposing | + | ==Predisposing factors== |
These include any condition causing: | These include any condition causing: | ||
− | |||
− | |||
− | |||
− | ==Clinical | + | ''joint trauma'': repetitive or acute trauma, intra-articular fractures |
+ | |||
+ | ''joint instability/dysplasia'': [[:Category:Joints - Degenerative Pathology|luxations and subluxations]], [[Hip Dysplasia|hip dysplasia]], [[Elbow Dysplasia|elbow dysplasia]], [[Cranial Cruciate Ligament Rupture|cruciate disease]] | ||
+ | |||
+ | ''joint incongruity'': conformational abnormalities, congenital malformations, [[Osteochondrosis|osteochondrosis]], [[Calve Legg-Perthe's Disease]] | ||
+ | |||
+ | ==Clinical signs== | ||
These include: '''lameness, pain, joint swelling, muscle atrophy, pericapsular fibrosis, crepitation and decreased range of motion'''. | These include: '''lameness, pain, joint swelling, muscle atrophy, pericapsular fibrosis, crepitation and decreased range of motion'''. | ||
Line 28: | Line 29: | ||
A history of joint disease is common. | A history of joint disease is common. | ||
− | '''Radiography''' will reveal: joint effusion, periarticular soft tissue swelling, osteophytosis, enthesitis, subchondral bone sclerosis and narrowed joint space. It is important to note that radiographic changes do not always correlate with clinical signs and not all degenerate joints are associated with lameness. | + | '''Radiography''' will reveal: joint effusion, periarticular soft tissue swelling, osteophytosis, enthesitis, subchondral bone sclerosis and narrowed joint space. |
+ | |||
+ | It is important to note that radiographic changes do not always correlate with clinical signs and not all degenerate joints are associated with lameness. | ||
'''Arthrocentesis''' is usually unremarkable, but may reveal slight changes in viscosity, colour and volume. | '''Arthrocentesis''' is usually unremarkable, but may reveal slight changes in viscosity, colour and volume. | ||
Line 44: | Line 47: | ||
Corticosteroids should only be given to severe, non-responsive cases and never combined with NSAIDs. | Corticosteroids should only be given to severe, non-responsive cases and never combined with NSAIDs. | ||
− | '''New therapies''': | + | '''New therapies''': acupuncture is become more popular in small animals. |
Neutraceuticals such as glycosamide sulphate, chondroitin sulphate and pentosan polysulphate might improve signs, however few controlled studies in dogs and horses are available to support any claims. | Neutraceuticals such as glycosamide sulphate, chondroitin sulphate and pentosan polysulphate might improve signs, however few controlled studies in dogs and horses are available to support any claims. | ||
Line 50: | Line 53: | ||
'''Surgical treatment options''' include: | '''Surgical treatment options''' include: | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
+ | '''Joint lavage''': minimally invasive and may help remove inflammatory mediators and improve clinical signs for several months | ||
+ | |||
+ | Salvage procedures such as: | ||
+ | |||
+ | '''Excision arthroplasty''': in small animals, for example Femoral Head and Neck Excision | ||
+ | |||
+ | '''Replacement arthroplasty''': total hip replacement and total elbow replacement in dogs | ||
− | + | '''Arthrodesis''': in all species depending on the joint, carpal arthrodesis in dogs, pastern and hock joint arthrodesis in horses, fetlock as a last resort. | |
− | + | '''Amputation''' in small animals in cases of intractable pain or where financial issues prevent any other treatment. | |
− | |||
− | |||
− | |||
− | + | Ultimately, DJD is an '''incurable disease''' and conservative treatment will only slow the progression of the disease. | |
− | + | '''Prognosis''' depends on the location and severity of the arthropathy, but is usually guarded for return to athletic function. | |
− | |||
==References== | ==References== | ||
Line 75: | Line 75: | ||
Corr, S. (2009) '''Locomotor module: osteoarthritis''' ''RVC student notes'' | Corr, S. (2009) '''Locomotor module: osteoarthritis''' ''RVC student notes'' | ||
− | |||
− | |||
− | + | [[Category:To Do - Helen]] | |
+ | [[Category:To Do - Review]] | ||
− | |||
− | |||
− | |||
[[Category:Joints - Degenerative Pathology]] | [[Category:Joints - Degenerative Pathology]] | ||
− | [[Category: | + | [[Category:To Do - Manson]] |
Revision as of 11:44, 1 August 2011
Also known as: DJD — Osteoarthritis — Degenerative arthritis — Osteroarthrosis
Introduction
Degenerative joint disease is the progressive deterioration of articular cartilage and is characterised by hyaline cartilage thinning, joint effusion and periarticular osteophyte formation.
Chondrocyte necrosis is initiated, degradative enzymes are released and synovitis, continued cartilage degradation and inflammation occur. There is loss of proteoglycans and lubrication in the joint.
Normal joint function is altered by abnormal cartilage congruency and joint capsule anatomy.
Pain, lameness and muscle atrophy develop secondary to joint dysfunction.
DJD is the end-stage to many common diseases of small and large animals and therefore prompt diagnosis and management of these diseases is critical in preventing the condition.
Predisposing factors
These include any condition causing:
joint trauma: repetitive or acute trauma, intra-articular fractures
joint instability/dysplasia: luxations and subluxations, hip dysplasia, elbow dysplasia, cruciate disease
joint incongruity: conformational abnormalities, congenital malformations, osteochondrosis, Calve Legg-Perthe's Disease
Clinical signs
These include: lameness, pain, joint swelling, muscle atrophy, pericapsular fibrosis, crepitation and decreased range of motion.
Diagnosis
A history of joint disease is common.
Radiography will reveal: joint effusion, periarticular soft tissue swelling, osteophytosis, enthesitis, subchondral bone sclerosis and narrowed joint space.
It is important to note that radiographic changes do not always correlate with clinical signs and not all degenerate joints are associated with lameness.
Arthrocentesis is usually unremarkable, but may reveal slight changes in viscosity, colour and volume.
In horses, less severe cases may require arthroscopy for diagnosis.
Treatment
Treatment should rely principally on rest, controlled exercise and pain relief.
In small animals, an important treatment parameter is weight reduction or control.
Exercise modification/physiotherapy: animals should be put on an appropriate exercise regimen, using analgesia initially and to control flare-ups. Some dogs enjoy hydrotherapy.
Drug therapies: should include NSAIDs and opioids in severe pain. In small animals, example include: carprofen and meloxicam systemically. In horses, systemic phenylbutazone can be given as well as intra-articular injections of steroids, hyaluronic acid and glycosaminoglycans. Corticosteroids should only be given to severe, non-responsive cases and never combined with NSAIDs.
New therapies: acupuncture is become more popular in small animals.
Neutraceuticals such as glycosamide sulphate, chondroitin sulphate and pentosan polysulphate might improve signs, however few controlled studies in dogs and horses are available to support any claims.
Surgical treatment options include:
Joint lavage: minimally invasive and may help remove inflammatory mediators and improve clinical signs for several months
Salvage procedures such as:
Excision arthroplasty: in small animals, for example Femoral Head and Neck Excision
Replacement arthroplasty: total hip replacement and total elbow replacement in dogs
Arthrodesis: in all species depending on the joint, carpal arthrodesis in dogs, pastern and hock joint arthrodesis in horses, fetlock as a last resort.
Amputation in small animals in cases of intractable pain or where financial issues prevent any other treatment.
Ultimately, DJD is an incurable disease and conservative treatment will only slow the progression of the disease.
Prognosis depends on the location and severity of the arthropathy, but is usually guarded for return to athletic function.
References
Kahn, C. (2005) Merck veterinary manual Merck and co
Corr, S. (2009) Locomotor module: osteoarthritis RVC student notes